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Abstract
Objective: This study aimed to investigate whether or not hypoxia-inducible factor-1α (HIF-1α) gene variants are
associated with the susceptibility and clinical characteristics of lumbar disc degeneration (LDD).
Methods: We examined 320 patients with LDD and 447 gender- and age-matched control subjects. We also
determined the HIF-1α gene variants, including C1772T (P582S) and G1790A (A588T) polymorphisms.
Results: Significant differences were observed in allelic and genotypic distributions of 1790 A > G polymorphisms
between LDD cases and control subjects. Logistic regression revealed that 1790 AA genotypes indicated a protective
effect against the development of LDD. The HIF-1α 1790 A > G polymorphisms also affected the severity of LDD as
evaluated based on the modified Japanese Orthopedic Association (mJOA) scores. The 1790 AA genotype carriers
exhibited significantly lower mJOA scores than AG and GG carriers. C1772T did not show any association with the
risk and severity of LDD.
Conclusion: Our study suggested that HIF-1α 1790 A > G polymorphisms may be used as a molecular marker to
determine the susceptibility and severity of LDD.
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Introduction
Lumbar disc degeneration (LDD) is a major cause of
disability and has been associated with low back pain [1–4].
LDD is caused by various intrinsic and extrinsic factors;
however, the etiology of LDD remains poorly understood.
Environmental factors such as age, gender, smoking habits,
overweight, and exposure to vibration may contribute to LDD
[3,5–7]. Studies have also revealed that the genetic
background may contribute to the development of LDD [8,9].
The lumbar disc tissue is avascular, although small discrete
capillary beds are found in the dorsal and ventral surfaces. For
this reason, nucleus pulposus cells commonly reside in a
hypoxic environment [10]. The functions of hypoxia-inducible
factor-1α (HIF-1α) and other factors associated with hypoxia in
the mechanism of LDD development has also been reported
[11].
HIF-1α functions as a key regulator of cellular responses to
hypoxia and other processes, including angiogenesis,
erythropoiesis, energy metabolism, vasomotor function, and
apoptotic/proliferative responses [12–14]. HIF-1α is expressed
in nucleus pulposus cells and has an important function in
regulating energy metabolism and matrix synthesis [15–17].
Another study has revealed that HIF-1α may function in the
survival of disc cells and the resorption of the herniated disc in
human intervertebral discs [18].
HIF-1α expression is regulated by gene polymorphism. In the
HIF-1α gene, two polymorphisms, namely, C1772T (P582S)
and G1790A (A588T) polymorphisms significantly increase
gene transcriptional activity; these polymorphisms are
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correlated with the increased expression of proteins compared
with the wild-type sequence HIF-1α C1772T polymorphism,
thereby leading to HIF-1α mRNA overexpression in patients
with prostate cancer [19,20].
Although HIF-1α expression has been observed in nucleus
pulposus cells, the function of HIF-1α gene polymorphisms in
LDD remains unknown. We postulated that the HIF-1α gene
variants may be related to the risk of LDD. In the present study,
the patients with LDD and the healthy control subjects were
enrolled to investigate whether or not HIF-1α gene variants are




This study was approved by the Ethical Committee of Fujian
Medical University (No. 2012-2-56). All of the participants
provided their written informed consent to participate in this
study.
Subject Enrollment
We examined 320 patients with LDD and 447 gender- and
age-matched control subjects from September 2008 to August
2012 in the affiliated hospital of our school. All of the patients
received MRI evaluation, and all of the control subjects were
evaluated by CT or MRI. The diagnosis of LDD was confirmed
by two orthopedic surgeons specializing in spinal diseases, but
these surgeons were unaware of the study design. The disc
degeneration grade was determined according to
Schneiderman’s classification of MRI [21]. The exclusion
criteria were listed as follows: a) subject with autoimmune and
inflammatory diseases; b) severe degenerative disc disease
with a collapsed intervertebral space; c) previous surgical
treatment in the lumbar spine; d) severe osteoporosis; and e)
segmental instability. The severity of LDD was evaluated based
on the modified Japanese Orthopedic Association (mJOA)
scoring system [22]. The following data were collected from the
participants: gender; age; body mass index (BMI); smoking
status; and family history of LDD.
HIF-1α genotyping
Genomic DNA was isolated from the peripheral blood
leukocytes according to standard protocols. Polymerase chain
reaction (PCR) was performed to amplify the 178 bp fragment
Table 1. Characteristics of subjects.
Variables Case n=320 Control n=447 P
Age(mean ± SD) 47.1 ± 7.2 47.0± 6.8 0.584
Gender (Male, %) 154 (48.1%) 213 (47.6%) 0.743
BMI(mean ± SD) 23.7 ± 3.5 23.5 ± 2.7 0.772
Smoking (%) 125 (39.1%) 104 (23.3%) 0.041
Family history (%) 58 (18.4%) 47 (8.3%) < 0.001
History of labor work (%) 120 (37.5%) 51 (11.4%) < 0.001
DM 62 (19.4%) 45 (10.1%) 0.0033
of exon 12 in the HIF-1α human gene by using 5ʹ-CAT GTA
TTT GCT GTT TTA AAG-3ʹ as the forward primer and 5ʹ-GAG
TCT GCT GGA ATA CTG TAA CTG-3ʹ as the reverse primer.
The mixture (30 µL) used for PCR contained 200 ng of the
template DNA, 0.2 mM of each dNTP, 0.5 µM of each forward
and reverse primer, 1.5 mM of MgCl2, 0.5 U of Taq
polymerase, and 3 µL of 10× PCR buffer. The PCR conditions
were listed as follows: denaturation at 95 °C for 5 min; 35
cycles of denaturation at 95 °C for 30 s; annealing at 61 °C for
30 s; extension at 70 °C for 1 min; and a final extension at 72
°C for 10 min. The PCR products were purified and sequenced
using the Big Dye Terminator kit (version 3.1) on an ABI
Prism® 3100 Automated DNA sequencer according to the
manufacturer’s protocol (Applied Biosystems, Foster City, CA).
HIF-1α and VEGF Western blot
A total of 134 herniated lumbar intervertebral discs were
collected during surgery from the patients with LDD and who
underwent surgical treatment. The samples (0.3 g to 0.5 g)
were homogenized and lysed. The extracts were resolved on
sodium dodecyl sulfate (SDS)-polyacrylamide gels and then
transferred to nitrocellulose membranes (BioRad). The proteins
were also resolved by electrophoresis on 8% to 12% SDS-
polyacrylamide gels and then transferred to polyvinylidene
difluoride membranes (Bio-Rad) by electroblot. The
membranes were blocked with 5% non-fat dry milk in TBST (50
mM Tris, pH 7.6, 150 mM NaCl, and 0.1% Tween 20) and
incubated overnight at 4 °C in 3% non-fat dry milk in TBST with
anti-Hsp70 (Stressgen, 1:4000), anti-HIF-1α (Novus Biological,
1;1000), VEGF (Santa Cruz,1:1000), and anti-GAPDH (Santa
Cruz, 1:2000) antibodies. Immunolabeling was detected using
an ECL reagent (Amersham Biosciences).
Statistical analysis
For each SNP, a chi-square test was performed to assess
Hardy-Weinberg equilibrium and the association between the
LDD cases and the control groups based on allelic and
genotypic frequencies. The characteristics of the LDD subjects
and the control subjects were compared by performing chi-
square or Student’s t-test according to the variable types.
Binary logistic regression test was performed to determine the
risk factor of LDD. The odds ratios (OR) and 95% confidence
intervals (CIs) were calculated by adjusting age, gender,
smoking status, and other clinical data. Results were
considered significantly different at P < 0.05. The Raytest TINA
software (http://www.raytest.de/service/raytest_catalog.html)
was used for western blot to perform densitometric analysis
and evaluate the expressions of HIF-1α and VEGF as
described previously [23]. Differences in the relative
expressions among different genotypes were compared by
ANOVA in SPSS software (Statistical Package for the Social
Sciences, version 16.0, SPSS Inc., Chicago, IL, USA).
HIF-1α Polymorphism and Susceptibility to LDD
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Results
Characteristics of the cases and the control subjects
Table 1 shows the demographic characteristics of the LDD
subjects and the control subjects. Gender, age, and BMI were
similar between the two groups. Smokers were more common
in the LDD subjects than in the control subjects (39.2% vs.
23.3%, P = 0.041). The patients with LDD exhibited a higher
percentage of DM than the control subjects (P = 0.033). The
incidence of positive family history was markedly higher in the
LDD group than in the control group (18.3% vs. 8.3%, P <
0.001).
Table 2 summarizes the allelic frequencies and genotypic
distributions of the SNPs in the LDD cases and the control
subjects. The genotypic distributions of each SNP were
consistent with Hardy-Weinberg equilibrium (P > 0.05). For
SNPs at 1772 C > T, no statistically significant difference was
observed in the distribution of the alleles and genotypes among
the patients and the control subjects (P = 0.982 and P = 0.482,
respectively). For SNPs at 1790 G > A, the AA prevalence was
markedly lower in the LDD cases than in the control subjects
(20.80% vs. 52.49%, P = 0.001). Allele analysis revealed that
the A allele frequencies were 43.25% and 48.5% in the patients
with LDD and the control subjects, respectively (P = 0.001).
Using GG as the reference, we conducted multivariate logistic
regression analysis and found that the AA genotype carriers
exhibited lower risks of developing LDD (adjusted OR = 2.15,
95% CI = 1.30–3.11, adjusted P = 0.002), in which age,
gender, BMI, smoking status, family history, history of labor,
and DM were adjusted.
We analyzed the association of HIF-1α SNPs and the
severity of LDD in the LDD subjects. The severity of LDD was
stratified according to HIF-1α genotypes. Figure 1 shows that
the severity of LDD was similar in the subjects with 1772 C > T
genotype (P > 0.05). However, the severity of LDD in the
subjects with 1790 A > G genotype were significantly different.
The genotype carriers of 1790 AA exhibited significantly lower
mJOA scores (9.6±0.2) than AG and GG carriers (11.7±0.2 and
12.0±0.3, respectively).
We compared HIF-1α and VEGF protein expressions in the
samples obtained from the patients with LDD. The
Characteristics and genotype distribution for 134 subjects
selected for western blot were shown in Table S1 and Table
S2. The herniated lumbar intervertebral discs collected from
Table 2. The genotype and allele distribution of HIF-1α gene SNPs in LDD cases and controls.
 LDD  Control       
 N % N % global P adjusted OR 95%CI adjusted P
1772CC 90 32.85% 101 33.55% 0.982 1    
1772CT 143 52.19% 156 51.83%  1.03 0.72 1.48 0.88
1772TT 41 14.96% 44 14.62%  1.05 0.63 1.74 0.86
C 323 58.94% 358 59.47% 0.452 1    
T 225 41.06% 244 40.53%  1.02 0.81 1.29 0.86
1790GG 94 34.31% 76 25.25% 0.011 1    
1790GA 123 44.89% 134 44.52%  0.74 0.5 1.1 0.13
1790AA 57 20.80% 91 30.23%  0.51 0.32 0.79 P<0.001
G 311 56.75% 286 47.51% 0.001 1    
A 237 43.25% 316 52.49%  0.69 0.55 0.87 P<0.001
Figure 1.  HIF-1α SNPs and the LDD severity within LDD subjects.  
doi: 10.1371/journal.pone.0073158.g001
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the patients with LDD exhibiting different genotypes underwent
surgical treatment. Figure 2 shows the typical bands of the
samples from the patients with LDD. We detected the HIF-1α
protein expression by western blot analyses. Our results
showed that the 1790 A > G SNPs significantly affected HIF-1α
and VEGF expressions. The HIF-1α and VEGF protein
expressions were significantly lower in 1790 AA carriers than in
1790 AG and 1790 GG carriers. VEGF expression was lower in
1790 AA carriers than in 1790 AG and 1790 GG carriers. By
contrast, 1772 C > T genotype did not exhibit any change in
HIF-1α and VEGF protein expressions. Quantitative analyses
by Raytest TINA software showed that the relative protein
expressions of VEGF were 0.33±0.03, 0.40±0.07, and
0.88±0.06 in 1790 AA, 1790 GA, and 1790 GG carriers,
respectively (P < 0.001, Figure 3a). The relative expressions of
HIF-1α were 0.25±0.01, 0.26±0.02, and 0.43±0.03 in 1790 AA,
1790 GA, and 1790 GG carriers, respectively (P < 0.001,
Figure 3b). These results indicated that the relative
expressions of VEGF and HIF-1α were not affected by 1172 C
> T genotypes.
Discussion
As the largest avascular tissue in the human body, the
nucleus pulposus contains cells that are morphologically similar
to cartilage cells. The nucleus pulposus is an aggrecan-rich
avascular tissue that permits the intervertebral disc to resist
compressive loads. The metabolism of such cells is performed
by capillary diffusion from the end plate of the cartilage found in
their vicinity [24]. HIF-1α is widely expressed in almost all cells
in the human body; HIF-1α is also a molecule that detects
oxygen stress and cell responses. HIF-1α is degraded under
normal oxygen stress and undergoes ubiquitination. However,
degradation is suppressed when the cells are exposed to
hypoxic condition; as a result, HIF-1α is amplified rapidly and
accumulates in cells [25].
An in vitro study showed that the oxygen-independent
stabilization of HIF-1α in nucleus pulposus cells is a metabolic
adaptation that initiates glycolysis and aggrecan expression
[16]. Another study has shown HIF-1α expression in the
intervertebral disc cells, in which HIF-1α also regulates the
apoptosis of intervertebral disc cells, suggesting that HIF-1α is
involved in the homeostasis of intervertebral disc cells [26].
The HIF-1α gene is located at chromosome 14q21–q24. In
vitro studies have demonstrated that the C1772T (P582S) and
G1790A (A588T) polymorphisms of the HIF-1α gene under
normoxic and hypoxic conditions show a higher transcriptional
activity correlated with the overexpression of the corresponding
protein than the transcriptional activity and protein expression
of the wild-type sequence [27–29]. In clinical practice, the
presence of these polymorphisms is associated with the
development of diseases such as cancer, diabetes, and
coronary disease, in which an altered HIF-1α is observed in
various groups among different populations [30–32].
Currently, studies on the association between HIF-1α and
LDD have not been published yet. A large-scale replication
study of the association of rs17039192 in HIF-2α with knee
osteoarthritis (OA) has revealed that rs17039192 in HIF-2α is
not positively associated with knee OA [33]. In the present
study, the association between SNPs of the HIF-1α gene and
the HIF-1α expression as well as the incidence and severity of
LDD was analyzed in a Chinese cohort. Significant differences
were observed in the allelic and genotypic distributions of the
1790 A > G polymorphisms between the LDD cases and the
control subjects. Logistic regression revealed that the 1790 AA
genotype represented a protective effect against the
Figure 2.  HIF-1α and VEGF protein expression in samples from LDD patients.  
doi: 10.1371/journal.pone.0073158.g002
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development of LDD. To the best of our knowledge, this study
is the first to report the function of HIF-1α gene SNPs in LDD.
The HIF-1α 1790 A > G polymorphisms also affected the
severity of LDD evaluated based on mJOA scores. The 1790
AA genotype carriers exhibited significantly lower mJOA scores
than AG and GG carriers. Our study suggested that the HIF-1α
1790 A > G polymorphisms may be used as a molecular
marker of the susceptibility and severity of LDD.
VEGF has an important function in physiological and
pathological angiogenesis. The upregulation of VEGF
expression in response to reduced oxygen stress occurs via
transcriptional and post-transcriptional mechanisms [34]. A
study in glioma cell has demonstrated that the binding site of
HIF1 is important to induce VEGF gene expression under
hypoxic conditions [35]. In visceral adipose tissues, hypoxia
induces VEGF synthesis [34]. In this study, the HIF-1α gene
polymorphisms in herniated lumbar intervertebral disc samples
from patients with LDD were investigated. We found that 1790
A > G SNPs, not 1772C > T SNPs, significantly affected HIF-1α
and VEGF expressions. VEGF and HIF-1α exhibited similar
expression patterns. This result supported our hypothesis that
the genetic polymorphisms of HIF-1α in LDD may occur by
changing the HIF-1α and VEGF expressions.
A previous study also revealed that HIF-1α expression is
strongly correlated with inflammation and angiogenesis in
rheumatoid arthritis [36]. We postulated that HIF-1α may
regulate the inflammation of intervertebral discs and influence
the development of LDD. Our ongoing animal study focuses on
the association between HIF-1α expression and inflammation
level in intervertebral disc tissues.
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